KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 77 filers reported holding KYMERA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,558,740 | +11.4% | 184,082 | +84.2% | 0.00% | 0.0% |
Q2 2023 | $2,297,046 | -17.5% | 99,915 | +6.3% | 0.00% | 0.0% |
Q1 2023 | $2,785,664 | +40.4% | 94,015 | +18.2% | 0.00% | +50.0% |
Q4 2022 | $1,984,694 | +14.4% | 79,515 | +1.1% | 0.00% | 0.0% |
Q3 2022 | $1,735,000 | +14.9% | 78,615 | +2.5% | 0.00% | 0.0% |
Q2 2022 | $1,510,000 | -57.2% | 76,676 | -8.1% | 0.00% | -33.3% |
Q1 2022 | $3,532,000 | -37.0% | 83,462 | -5.5% | 0.00% | -40.0% |
Q4 2021 | $5,607,000 | +40.5% | 88,320 | +29.9% | 0.01% | +25.0% |
Q3 2021 | $3,992,000 | +2.6% | 67,965 | +5.1% | 0.00% | 0.0% |
Q2 2021 | $3,892,000 | +276.4% | 64,665 | +143.1% | 0.00% | +300.0% |
Q1 2021 | $1,034,000 | -27.5% | 26,599 | +15.6% | 0.00% | -50.0% |
Q4 2020 | $1,426,000 | +98.9% | 23,001 | +3.6% | 0.00% | +100.0% |
Q3 2020 | $717,000 | – | 22,201 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AJU IB Investment Co., Ltd. | 639,059 | $37,538,000 | 24.22% |
BVF INC/IL | 3,180,658 | $186,832,000 | 7.29% |
Deer IX & Co. Ltd. | 615,895 | $36,178,000 | 3.72% |
Asymmetry Capital Management, L.P. | 89,071 | $5,232,000 | 3.14% |
Redmile Group, LLC | 2,793,708 | $164,102,000 | 2.86% |
SPHERA FUNDS MANAGEMENT LTD. | 359,260 | $21,103,000 | 1.77% |
CLOUGH CAPITAL PARTNERS L P | 271,000 | $15,919,000 | 0.96% |
Rock Springs Capital Management LP | 732,927 | $43,052,000 | 0.90% |
Eagle Health Investments LP | 37,000 | $2,173,000 | 0.69% |
Avidity Partners Management LP | 514,500 | $30,222,000 | 0.67% |